Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea - 16/06/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | The current study is the first systematic review on NAFLD prevalence in Korea. |
• | The overall NAFLD prevalence in Korea was 30.3% as two-fold higher in men (41.4%) than women (20.3%). |
• | The prevalence of NAFLD in Korea was further analyzed according to gender, age, severity, and BMI in this study. |
Abstract |
Aims |
We aimed to conduct a systematic review and a meta-analysis to estimate NAFLD prevalence and its change in Korea.
Methods |
We searched the literature involving NAFLD prevalence in Korea in PubMed, RISS, and KMBASE from inception to June 2017. Studies with subjects with certain disorders, population limitations, or subjects who consume alcohol were excluded. Analysis was stratified by publication year, age, gender, severity, body mass index (BMI), and diagnostic technique. Random-effects models were used to provide point estimates (95% confidence interval) of prevalence with subgroup analysis to account for heterogeneity.
Results |
A total of 61 studies (837,897 participants) were included. The overall NAFLD prevalence in Korea was 30.3% (men: 41.1%, women: 20.3%), with a slight increase from 29.0% to 31.0% over an approximately 10-year period. BMI significantly affected NAFLD prevalence (≤ or > 25 kg/m2, 12.3% vs. 41.7%, p < 0.001), while women were significantly affected by aging (< or ≥ 50 years, 17.0% vs. 25.8%, p < 0.01). The prevalence of steatosis by severity was 22.6% for mild, 9.8% for moderate to severe and 2.2% for nonalcoholic steatohepatitis (NASH), with different patterns by gender.
Conclusion |
The current study is the first systematic analysis on NAFLD prevalence in Korea and found a change in NAFLD prevalence during the recent decade.
Le texte complet de cet article est disponible en PDF.Keywords : Steatosis, Steatohepatitis, Epidemiology, Asia
Abbreviations : NAFLD, BMI, CI, NASH, HCV, FLI, CT, VLDL, NAFL, WHO
Plan
Vol 45 - N° 4
Article 101526- juillet 2021 Retour au numéro
Article précédent
- The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma
- Wenjuan Liu, Chunlin Xu, Qingyang Meng, Peng Kang
- Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort
- Alejandro Campos-Murguía, Pedro Valdéz-Hernández, Jacqueline Cordova-Gallardo, Jazmín Arteaga-Vázquez, Alan G. Contreras, Mario Vilatobá, Rodrigo Cruz-Martínez, Braulio Martínez-Benítez, Armando Gamboa-Domínguez, Braulio A. Marfil-Garza, Nayelli C. Flores-García, Ernesto Márquez-Guillén, Ignacio García-Juárez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?